Medtech company BD invests €36 million to expand Drogheda operations
In more good news for Drogheda today, medical technology company BD (Becton, Dickinson and Company) has announced an investment of €36 million that will create up to 20 additional jobs at its facility.
BD produces BD PosiFlush syringes and safety components for insulin injection at its site in Louth.
The investment will see two new production lines installed at the Drogheda plant. BD Medical Plant Manager, Liam Dillon, believes that the ongoing investment reiterates the company’s commitment to the 130 employees on site, the local community and Ireland, as a whole.
He said: “We are delighted that BD has invested €36 million on two new production lines. It will […] allow us to expand production of PD PosiFlush syringes, which are used in hospitals and medical centres throughout the world. Our team here in Drogheda will continue to manufacture high-quality products that contribute to the health and well-being of patients worldwide.”
BD’s history in Ireland dates back to 1964, when it became one of the first medical device companies to set up in the country.
The investment was supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
Martin Shanahan, CEO of IDA Ireland, comments: “Today’s announcement that Becton Dickinson is to create an additional 20 jobs and invest €36million at their Drogheda plant is a significant boost for the local economy of the North East region. This investment demonstrates the company’s long term commitment to Ireland and builds on its 50-year history in Drogheda.”